Detected ·
Aureka Biotechnologies, Inc.
$100M—
Aureka Biotechnologies, Inc. raised $100M in Series B funding to build a biological world model for drug discovery, bringing total capital raised to nearly $200M. The round was led by Granite Asia and a strategic investor, with participation from HighLight Capital, MPCi 经纬创投, and 纽尔利资本 NRL Capital.
- Website
- www.aurekabio.com
- linkedin.com/company/aurekabio
- Amount
- $100 000 000 USD
- Stage
- —
- Event
- Funding round
- Detected
- 2026-08-13 00:05:18 UTC
- Signal ID
- 7c4ccc90-a55e-49fb-853f-5f253019e9fd
As the API returns it
{
"id": "7c4ccc90-a55e-49fb-853f-5f253019e9fd",
"created_at": "2026-08-13T00:05:18.332517Z",
"company_name": "Aureka Biotechnologies, Inc.",
"company_website_url": "www.aurekabio.com",
"company_linkedin_url": "https://www.linkedin.com/company/aurekabio",
"event_type": "funding",
"funding_amount": 100000000,
"funding_currency": "USD",
"funding_stage": null,
"message": "*Aureka Biotechnologies, Inc. raised $100M in Series B funding to build a biological world model for drug discovery, bringing total capital raised to nearly $200M. The round was led by Granite Asia and a strategic investor, with participation from HighLight Capital, MPCi 经纬创投, and 纽尔利资本 NRL Capital.*"
}